Advertisement

Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81
Document › Details

Thermo Fisher Scientific Inc.. (8/9/11). "Press Release: Thermo Fisher Scientific Announces Offering of Senior Notes". Waltham, MA.

Region Region United States (USA)
Organisation Organisation Thermo Fisher Scientific Inc. (NYSE: TMO)
  Group Thermo Fisher (Group)
Products Product diagnostics (medical/biological)
  Product 2 investment banking
Persons Person O’Brien, Ron (Thermo Fisher 201003 Director Public Relations)
  Person 2 Apicerno, Ken (Thermo Fisher 201003 Investor Relations)
     


Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it intends to offer senior notes to fund, in part, its acquisition of Phadia. The aggregate purchase price of this transaction is estimated to be EUR 2.47 billion (approximately $3.5 billion). The Phadia acquisition was announced by the company on May 19, 2011.

The joint book-running managers for the offering are Barclays Capital Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC.

Thermo Fisher has filed a registration statement on Form S-3 (including a prospectus) with the Securities and Exchange Commission (the "SEC") for this offering. Prospective investors should read the prospectus forming a part of that registration statement and the preliminary prospectus supplement related to the offering and the other documents that the company has filed with the SEC for more complete information about the company and this offering. These documents are available at no charge by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, these documents will be made available upon request by the company or by any underwriter or dealer participating in the offering. Interested parties may obtain a prospectus or the related preliminary prospectus supplement from Barclays Capital Inc. by directing a request to Barclays Capital Inc., c/o Broadridge Integrated Prospectus Distribution, 1155 Long Island Avenue, New York, NY 11717, or by calling 1-888-603-5847; from Merrill Lynch, Pierce, Fenner & Smith Incorporated by directing a request to 1-800-294-1322 or from J.P. Morgan Securities LLC by directing a request to J.P. Morgan Securities LLC, 383 Madison Avenue, New York, NY 10179, Attn: High Grade Syndicate Desk - 3rd Floor or by calling 212-834-4533.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the notes, nor shall there be any offer, solicitation or sale of the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.


Thermo Fisher Scientific Inc.

Media Contact Information:
Ron O'Brien, 781-622-1242
ron.obrien@thermofisher.com
Website: www.thermofisher.com

or

Investor Contact Information:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com

   
Record changed: 2016-03-19

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Thermo Fisher (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px




» top